Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6521261 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 02/18/2003 |
| 6471994 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 10/29/2002 |
| 6395303 | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose The present invention provides an improved process for the preparation of a agglomerated solid dosage form, comprising preparing an aqueous slurry of microcrystalline cellulose and a microcrystalline cellulose compressibility augmenting agent and an activ... | 05/28/2002 |
| 6391337 | Directly compressible high load acetaminophen formulations Direct compressed solid pharmaceutical dosage forms containing: a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and c) from about 0.01 to about 4.0%... | 05/21/2002 |
| 6245356 | Sustained release heterodisperse hydrogel systems-amorphous drugs Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and u... | 06/12/2001 |
| 6245355 | Sustained release matrix for high-dose insoluble drugs Sustained release dosage forms of high dose insoluble drugs such as ibuprofen and methods for their manufacture are disclosed.... | 06/12/2001 |
| 6217909 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 04/17/2001 |
| 6217907 | Directly compressible high load acetaminophen formulations Direct compressed solid pharmaceutical dosage forms containing: a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and c) from about 0.01 to about 4.0%... | 04/17/2001 |
| 6136343 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 10/24/2000 |
| 6106865 | Pharmaceutical excipient having improved compressibility A composition, comprising (a) microcrystalline cellulose; and (b) a compressibility augmenting agent which (i) physically restricts the proximity of the interface between adjacent cellulose surfaces; or (ii) inhibits interactions between adjacent cellulos... | 08/22/2000 |
| 6103219 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 08/15/2000 |
| 6093420 | Sustained release matrix for high-dose insoluble drugs Sustained release dosage forms of high dose insoluble drugs such as ibuprofen and methods for their manufacture are disclosed.... | 07/25/2000 |
| 6056977 | Once-a-day controlled release sulfonylurea formulation This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Further, the use of an aqueous alk... | 05/02/2000 |
| 6048548 | Sustained release heterodisperse hydrogel systems-amorphous drugs Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and u... | 04/11/2000 |
| 6039980 | Sustained release excipient A sustained-release formulation for use in oral solid dosage forms includes from about 10 to about 40 percent or more by weight galactomannan gum; from about 1 to about 20 percent by weight of an ionizable gel strength enhancing agent and an inert pharmac... | 03/21/2000 |
| 5965166 | Directly compressible high load acetaminophen formulations Direct compressed solid pharmaceutical dosage forms containing: a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and c) from about 0.01 to about 4.0%... | 10/12/1999 |
| 5958456 | Controlled release formulation (albuterol) A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an op... | 09/28/1999 |
| 5948438 | Pharmaceutical formulations having improved disintegration and/or absorptivity An oral solid dosage form, comprising a compressed tablet including an excipient comprising (a) microcrystalline cellulose; and (b) a compressibility augmenting agent which (I) physically restricts the proximity of the interface between adjacent cellulose... | 09/07/1999 |
| 5866166 | Pharmaceutical excipient having improved compressibility A composition, comprising (a) microcrystalline cellulose; and (b) a compressibility augmenting agent which (i) physically restricts the proximity of the interface between adjacent cellulose surfaces; or (ii) inhibits interactions between adjacent cellulos... | 02/02/1999 |
| 5858412 | Sustained release formulations utilizing pharmaceutical excipient having improved compressibility with modified microcrystalline Sustained release formulations include an augmented microcrystalline cellulose, an active agent, and a sustained release carrier and methods for making same are disclosed.... | 01/12/1999 |
| 5846563 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 12/08/1998 |
| 5773025 | Sustained release heterodisperse hydrogel systems--amorphous drugs Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and u... | 06/30/1998 |
| 5741524 | Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility Sustained release formulations include an augmented microcrystalline cellulose, an active agent, and a sustained release carrier and methods for making same are disclosed.... | 04/21/1998 |
| 5738865 | Controlled release insufflation carrier for medicaments Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which preferably includes one or more polysaccharide gums of natur... | 04/14/1998 |
| 5733578 | Directly compressible high load acetaminophen formulations Direct compressed solid pharmaceutical dosage forms containing: a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and c) from about 0.01 to about 4.0%... | 03/31/1998 |
| 5725883 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 03/10/1998 |
| 5725884 | Pharmaceutical excipient having improved compressibility A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles an... | 03/10/1998 |
| 5670168 | Agglomerated hydrophilic complexes with multi-phasic release characteristics The present invention relates to a controlled release formulation which includes a therapeutically active medicament, a heterodisperse gum matrix, a pharmaceutically acceptable diluent, and an effective amount of a pharmaceutically acceptable surfactant a... | 09/23/1997 |
| 5667801 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 09/16/1997 |
| 5665414 | Cellulosic materials for incorporation into food products and methods of making same New cellulosic materials derive from pulps having an ISO brightness of from 80 to about 90 are disclosed. The celluloses substantially match the color of the food products admixed therewith to provide food products such as sauces, emulsions, frozen desser... | 09/09/1997 |
| 5662933 | Controlled release formulation (albuterol) A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an op... | 09/02/1997 |
| 5612053 | Controlled release insufflation carrier for medicaments Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which preferably includes one or more polysaccharide gums of natur... | 03/18/1997 |
| 5554387 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 09/10/1996 |
| 5512297 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 04/30/1996 |
| 5478574 | Agglomerated hydrophilic complexes with multi-phasic release characteristics The present invention relates to a controlled release formulation which includes a therapeutically active medicament, a heterodisperse gum matrix, a pharmaceutically acceptable diluent, and an effective amount of a pharmaceutically acceptable surfactant a... | 12/26/1995 |
| 5472711 | Agglomerated hydrophilic complexes with multi-phasic release characteristics The present invention relates to a controlled release formulation which includes a therapeutically active medicament, a heterodisperse gum matrix, a pharmaceutically acceptable diluent, and an effective amount of a pharmaceutically acceptable surfactant a... | 12/05/1995 |
| 5455046 | Sustained release heterodisperse hydrogel systems for insoluble drugs A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. I... | 10/03/1995 |
| 5399359 | Controlled release oxybutynin formulations A solid oral sustained release oxybutynin formulation includes a sustained release matrix including a gelling agent, an inert pharmaceutical diluent, and a cationic cross-linking agent.... | 03/21/1995 |
| 5399362 | Once-a-day metoprolol oral dosage form A sustained release oral solid dosage form of metoprolol pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, a cationic cross-linking agent. The formulation provides release of meto... | 03/21/1995 |
| 5399358 | Sustained release formulations for 24 hour release of metroprolol A sustained release oral solid dosage form of metoprolol pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, a cationic cross-linking agent, and metoprolol provides release of metop... | 03/21/1995 |
